PSYCF (Psyched Wellness) 3-Year EBITDA Growth Rate: 15.70% (As of May. 2026) — 35% Above Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Psyched Wellness 3-Year EBITDA Growth Rate?

Psyched Wellness PSYCF +1.45% 3-Year EBITDA Growth Rate is 15.70% as of May. 2026, which is 35% above its 10-year median of 11.60. The stock has 1 warning sign investors should review. Among 1,663 Consumer Packaged Goods companies, Psyched Wellness ranks better than 63.98% on this metric.

Psyched Wellness's EBITDA per Share for the three months ended in May. 2026 was $-0.00.

During the past 3 years, the average EBITDA Per Share Growth Rate was 15.70% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 12.60% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -17.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Psyched Wellness was 69.70% per year. The lowest was -310.20% per year. And the median was 11.60% per year.


Psyched Wellness  (OTCPK:PSYCF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Psyched Wellness 3-Year EBITDA Growth Rate Related Terms


PSYCF vs KHC, GIS: 3-Year EBITDA Growth Rate Comparison

For the Packaged Foods subindustry, Psyched Wellness's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Psyched Wellness 3-Year EBITDA Growth Rate vs Consumer Packaged Goods Industry

For the Consumer Packaged Goods industry and Consumer Defensive sector, Psyched Wellness's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Psyched Wellness's 3-Year EBITDA Growth Rate falls into.



Psyched Wellness 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of 15.70% mean?
Psyched Wellness (PSYCF) has a 3-Year EBITDA Growth Rate of 15.70% as of May. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Psyched Wellness and its competitors. This is 35% above median its historical median of 11.60. According to the industry distribution chart, Psyched Wellness ranks #599 out of 1663 companies in the Consumer Packaged Goods industry, placing it in the top 36%.
Is Psyched Wellness' 3-Year EBITDA Growth Rate too high?
Psyched Wellness' current 3-Year EBITDA Growth Rate of 15.70% is 35% above median its 10-year median of 11.60. The Consumer Packaged Goods industry median 3-Year EBITDA Growth Rate is 7.90. Psyched Wellness' value of 15.70% is 98.7% above this industry median. Based on the distribution chart, Psyched Wellness ranks #599 out of 1663 companies in the Consumer Packaged Goods industry, which is above the industry midpoint.
How does Psyched Wellness' 3-Year EBITDA Growth Rate compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Psyched Wellness ranks #599 out of 1663 companies for 3-Year EBITDA Growth Rate. This puts Psyched Wellness in the upper half of its industry. The industry median 3-Year EBITDA Growth Rate is 7.90. Psyched Wellness' value of 15.70% is 98.7% above this benchmark. While the company's 10-year median is 11.60 vs. the industry median of 7.90, Psyched Wellness has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Consumer Packaged Goods company?
The median 3-Year EBITDA Growth Rate among Consumer Packaged Goods companies is 7.90, based on 1,663 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Psyched Wellness's current 3-Year EBITDA Growth Rate of 15.70% is 98.7% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Psyched Wellness and its competitors. For the Consumer Packaged Goods industry, the median 3-Year EBITDA Growth Rate is 7.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Psyched Wellness's current 3-Year EBITDA Growth Rate is 15.70%, which is 35% above median its own 10-year median of 11.60. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Psyched Wellness stock overvalued right now?
Based on GuruFocus' analysis, Psyched Wellness (PSYCF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.05, compared to a current price of $0.01 — trading 86% below its estimated fair value. The current 3-Year EBITDA Growth Rate is 15.70%, which is 35% above median its 10-year median of 11.60 and 98.7% above the Consumer Packaged Goods industry median of 7.90. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Psyched Wellness (PSYCF), the current 3-Year EBITDA Growth Rate is 15.70% as of May. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Psyched Wellness Business Description

Other Exchanges 5U9:GermanyPSYC:Canada
Address 36 Toronto Street, Suite 701, Toronto, ON, CAN, M5C 2C5
Psyched Wellness Ltd is a Canada-based health supplements company, which is engaged in the distribution of mushroom-derived products and associated consumer packaged goods. The Company is producing and developing a line of Amanita Muscaria-derived water-based extracts, teas and capsules designed to help with three health objectives, such as promote stress relief, relaxation, and assist with restful sleeping. The Company's subsidiaries include Psyched Wellness Corp., and AME Wellness Inc.